Press Release Archive - 2010

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

22 Dec 2010

Antares Pharma Announces Filing of New Drug Application For Anturol For Overactive Bladder
READ  

19 Nov 2010

Antares Pharma Announces Next Generation of Auto-Injector Design
READ  

28 Jun 2010

Antares Pharma added to Russell 3000 Index
READ  

02 Feb 2010

Antares Teva Tjet
READ  

04 May 2010

Antares Pharma Announces Receipt of Sales-Based Milestone Payment from TEVA
READ  

06 May 2010

Antares Pharma to Host First Quarter 2010 Earnings Call
READ  

19 May 2010

Antares Pharma Announces Receipt of Milestone Payment from Ferring
READ  

13 May 2010

Antares Pharma Reports First Quarter 2010 Financial and Operating Results
READ  

22 Dec 2010

Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder
READ  

19 Nov 2010

Antares Pharma Announces Next Generation of Auto-Injector Design
READ  

10 Nov 2010

Antares Pharma Reports Third Quarter 2010 Financial and Operating Results
READ  

03 Nov 2010

Antares Pharma Awarded Qualifying Therapeutic Discovery Project Grants for Anturol
READ  

03 Nov 2010

Antares Pharma to Host Third Quarter 2010 Earnings Call
READ  

27 Oct 2010

Antares Pharma to Present at the 21st Annual Oppenheimer Conference
READ  

17 Sep 2010

Antares Pharma Announces Planned Departure of Senior Executive
READ  

12 Aug 2010

Antares Pharma Reports Second Quarter 2010 Financial and Operating Results
READ  

04 Aug 2010

Antares Pharma to Host Second Quarter 2010 Earnings Call
READ  

29 Jul 2010

Antares Pharma to Present at the BMO 10th Annual Focus on Healthcare Conference
READ  

27 Jul 2010

Antares Pharma Announces Positive Top Line Results From Its Pivotal Phase 3 Study of Anturol Gel for the Treatment of Overactive Bladder
READ  

27 Apr 2010

ANTARES PHARMA and UMAN PHARMA Enter Collaboration for VIBEX™ MTX
READ  

20 Jan 2010

Antares Pharma expands Executive Team and appoints Pavan Handa as Senior Vice President of Business Development
READ